Clinical Trial Update: Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether repeat administration of eslicarbazepine acetate affects the pharmacokinetics of a combined oral contraceptive in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Combined oral contraceptive
• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Partial Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-12